Target Name: RNA5S3
NCBI ID: G100169754
Review Report on RNA5S3 Target / Biomarker Content of Review Report on RNA5S3 Target / Biomarker
Other Name(s): RNA, 5S ribosomal 3 | RN5S3

RNA5S3: A Potential Drug Target and Biomarker

RNA-based technologies have revolutionized the field of genetics and have led to the discovery of many promising biomarkers and drug targets. One of these targets is RNA5S3, which has been identified as a potential drug target and biomarker.

RNA5S3 is a RNA molecule that is expressed in most tissues of the body. It is a key regulator of gene expression and has been shown to play a role in the development and progression of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key features of RNA5S3 is its ability to interact with other molecules in the cell. It has been shown to form complex with a variety of proteins, including transcription factors, which can enhance its stability and enhance its ability to influence gene expression.

This interaction between RNA5S3 and transcription factors makes it a promising target for drugs that are designed to inhibit its activity. By doing so, these drugs can potentially reduce the level of gene expression and reduce the risk of disease.

In addition to its potential as a drug target, RNA5S3 has also been identified as a potential biomarker. Its expression has been shown to be highly correlated with the severity of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

This suggests that RNA5S3 may be a useful biomarker for the diagnosis and prognosis of these diseases. It is also possible that it may be possible to use RNA5S3 as a target for drug development, particularly for diseases that are characterized by inflammation and over-expression of RNA5S3.

Overall, RNA5S3 is a promising target for drug development and a potential biomarker for the diagnosis and prognosis of many diseases. Further research is needed to fully understand its potential and to develop safe and effective drugs that can target RNA5S3.

Protein Name: RNA, 5S Ribosomal 3

The "RNA5S3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA5S3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at

More Common Targets

RNA5S4 | RNA5S9 | RNA5SP111 | RNA5SP115 | RNA5SP116 | RNA5SP129 | RNA5SP151 | RNA5SP162 | RNA5SP165 | RNA5SP174 | RNA5SP175 | RNA5SP178 | RNA5SP18 | RNA5SP180 | RNA5SP183 | RNA5SP185 | RNA5SP187 | RNA5SP19 | RNA5SP194 | RNA5SP195 | RNA5SP196 | RNA5SP197 | RNA5SP20 | RNA5SP201 | RNA5SP205 | RNA5SP207 | RNA5SP217 | RNA5SP233 | RNA5SP236 | RNA5SP242 | RNA5SP268 | RNA5SP282 | RNA5SP284 | RNA5SP318 | RNA5SP323 | RNA5SP329 | RNA5SP33 | RNA5SP335 | RNA5SP339 | RNA5SP343 | RNA5SP344 | RNA5SP345 | RNA5SP352 | RNA5SP353 | RNA5SP363 | RNA5SP371 | RNA5SP374 | RNA5SP378 | RNA5SP379 | RNA5SP385 | RNA5SP389 | RNA5SP390 | RNA5SP393 | RNA5SP410 | RNA5SP425 | RNA5SP437 | RNA5SP44 | RNA5SP444 | RNA5SP450 | RNA5SP456 | RNA5SP463 | RNA5SP464 | RNA5SP465 | RNA5SP479 | RNA5SP493 | RNA5SP496 | RNA5SP497 | RNA5SP505 | RNA5SP511 | RNA5SP518 | RNA5SP52 | RNA5SP53 | RNA5SP54 | RNA5SP57 | RNA5SP63 | RNA5SP85 | RNA5SP91 | RNASE1 | RNASE10 | RNASE11 | RNASE11-AS1 | RNASE12 | RNASE13 | RNASE2 | RNASE2CP | RNASE3 | RNASE4 | RNASE6 | RNASE7 | RNASE8 | RNASE9 | RNASEH1 | RNASEH1-DT | RNASEH2A | RNASEH2B | RNASEH2B-AS1 | RNASEH2C | RNASEH2CP1 | RNASEK | RNASEL